MicroPort Scientific ( (HK:0853) ) has issued an announcement.
Shanghai MicroPort Endovascular MedTech, a subsidiary of MicroPort Scientific, reported a decline in revenue and profit for the first quarter of 2025 compared to the same period in 2024. Despite the decrease in financial performance, the company’s total assets and equity showed slight growth, indicating a stable financial position amid challenging market conditions.
More about MicroPort Scientific
MicroPort Scientific Corporation operates in the medical technology industry, focusing on innovative medical devices and solutions. The company is involved in endovascular and cardiovascular products, with a market focus on advancing healthcare through technological innovation.
YTD Price Performance: 14.47%
Average Trading Volume: 1,850
Technical Sentiment Signal: Buy
Current Market Cap: $1.6B
See more data about 0853 stock on TipRanks’ Stock Analysis page.